Allarity Therapeutics (ALLR) Minority Interest (2021 - 2023)

Allarity Therapeutics' (ALLR) quarterly Minority Interest came in at $2.8 million in Q1 2023, up 37.94% on a QoQ basis from $2.0 million in Q4 2022.

Allarity Therapeutics (ALLR) Minority Interest (2021 - 2023) Analysis & Trends

Allarity Therapeutics (ALLR) has 3 years of Minority Interest data on file, last reported at $2.8 million in Q1 2023.

Quarterly Minority Interest changed N/A year-over-year to $2.8 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $2.8 million (changed N/A YoY) and the FY2022 annual result came in at $2.0 million, up 216.93% from the prior year.
Minority Interest rose to $2.8 million in Q1 2023, from $2.0 million in the prior quarter.
In the past five years, Minority Interest ranged from a high of $2.8 million in Q1 2023 to a low of $632000.0 in Q4 2021.
A 3-year average of $1.8 million and a median of $2.0 million in 2022 frame the typical range for Minority Interest.
The widest YoY moves for Minority Interest: up 216.93% in 2022, down 216.93% in 2022.
Tracing ALLR's Minority Interest over 3 years: stood at $632000.0 in 2021, then soared by 216.93% to $2.0 million in 2022, then surged by 37.94% to $2.8 million in 2023.
The last three Minority Interest figures came in at $2.8 million (Q1 2023), $2.0 million (Q4 2022), and $632000.0 (Q4 2021), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Allarity Therapeutics	23.23 Mn	23.23 Mn	-

Download Data